Skip to main content
Published locations for HER2-negative BC: Better pathological response with nab-paclitaxel vs. docetaxel in real world
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
HER2-negative BC: Better pathological response with nab-paclitaxel vs. docetaxel in real world
User login
Username
Password
Reset your password
/content/her2-negative-bc-better-pathological-response-nab-paclitaxel-vs-docetaxel-real-world
/hematology-oncology/article/252020/breast-cancer/her2-negative-bc-better-pathological-response-nab
/breast-cancer-icymi/article/252020/breast-cancer/her2-negative-bc-better-pathological-response-nab